Target intelligence / Profile preview

Crystallin gamma G, pseudogene (CRYGGP)

Target
CRYGGP
Molecular classification
Other (pseudogene, non-coding sequence), pseudogene, non-coding sequence, crystallin family member
01

Overview

Crystallin gamma G, pseudogene (CRYGGP), also referred to as CRYGGP1 or crystallin, gamma G pseudogene 1, is a non-protein-coding member of the crystallin gene family. The crystallin proteins are major structural components of the vertebrate eye lens, crucial for transparency and refractive index. Gamma-crystallins are highly stable, symmetrical, monomeric proteins organized in gene clusters with pseudogenes in the human genome. CRYGGP is one of three tandemly arranged gamma-crystallin pseudogenes (gamma-E, gamma-F, gamma-G) found on chromosome 2. It is not translated into a functional protein and is generally not involved in any known biological processes or disease phenotypes, serving purely as a vestigial genomic sequence. Unlike functional, protein-coding gamma-crystallin genes (gamma-A to gamma-D) which have defined roles and disease associations (e.g., cataract formation), CRYGGP is not a therapeutic target, biomarker, or drug target, nor is it a functional receptor, enzyme, or transporter with drug interactions. It is a non-functional pseudogene. Information related to functional gamma-crystallin proteins (e.g., CRYGA, CRYGB, CRYGD) is distinct and holds biological/clinical relevance.

Other names
CRYGGP1crystallin, gamma G pseudogene 1

Beyond the preview

Go deeper on Crystallin gamma G, pseudogene (CRYGGP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Crystallin gamma G, pseudogene (CRYGGP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call